E815
TEAS SECTION 8 & 15 RECEIVED
06/22/2026
Back to search
Official data from USPTO
NOVADOZ VALUE IN EVERY DOSE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
06/23/2026
Trademark type
Combined
Nice classes
5
Filing date
04/11/2018
Registration date
07/14/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/14/2020
Last transaction
06/23/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/08/2018
First use in commerce
01/08/2018
Drawing code
3
Owner type
16
Owner location
Piscataway, NJ, US
Examiner
BROWN, TRICIA
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "NOVADOZ" with the letter "A" depicted as an upward pointing arrow head. The tagline "VALUE IN EVERY DOSE" is written under starting from the letter "V". The word "VALUE" in the tag line is written under the letters "VA".
Holders and representatives
Holders
Novadoz Pharmaceuticals LLC
Representatives
Novadoz Pharmaceuticals LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations to treat infectious and parasitic diseasesneoplasmsdiseases of the blood and blood-forming organs and certain disorders involving the immune mechanismendocrinenutritional and metabolic diseasesmentalbehavioral and neuro developmental disordersdiseases of the nervous systemdiseases of the eye and adnexadiseases of the ear and mastoid processdiseases of the circulatory systemdiseases of the respiratory systemdiseases of the digestive systemdiseases of the skin and subcutaneous tissuediseases of the musculoskeletal system and connective tissuediseases of the genitourinary systempregnancychildbirth and the puerperiumcongenital malformationsdeformations and chromosomal abnormalities
Publications
History of USPTO decisions and trademark events.
39 publications found
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/14/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
07/14/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/11/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/10/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/28/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/28/2020
ALIE
ASSIGNED TO LIE
05/27/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/21/2020
DOCK
ASSIGNED TO EXAMINER
05/12/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/12/2019
GNRT
NON-FINAL ACTION E-MAILED
12/12/2019
CNRT
SU - NON-FINAL ACTION - WRITTEN
12/12/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/22/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/22/2019
IUAF
USE AMENDMENT FILED
11/13/2019
EISU
TEAS STATEMENT OF USE RECEIVED
11/13/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/11/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/16/2019
PUBO
PUBLISHED FOR OPPOSITION
04/16/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/27/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/14/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/12/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
03/12/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/12/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
03/12/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/12/2019
ZZBX
ALLOWANCE WITHDRAWN-INADVERTENTLY ISSUED ACTION
03/12/2019
PBSR
WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST
03/12/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/08/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/15/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/15/2019
ALIE
ASSIGNED TO LIE
02/07/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/02/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/07/2018
GNRT
NON-FINAL ACTION E-MAILED
08/07/2018
CNRT
NON-FINAL ACTION WRITTEN
08/07/2018
DOCK
ASSIGNED TO EXAMINER
07/31/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/19/2018
Continuous trademark protection
Get notified about every new filing that threatens NOVADOZ VALUE IN EVERY DOSE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.